|
PRPO | Precipio, Inc. |
|
|
PRPO | Precipio, Inc. |
| Laboratory Analytical Instruments |
| Book value per $ invested | $ 0.42 |
| Leverage | 35.00% |
| Market Cap | $ 33.0m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -1.3m |
| Margin | -5.32% |
Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. The company is headquartered in New Haven, Connecticut.